Bluejay Diagnostics, Inc.
BJDX
$4.01
-$0.02-0.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 810.00K | 862.80K | 1.09M | 1.10M | 943.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.36M | 1.90M | 2.43M | 2.39M | 2.34M |
| Operating Income | -1.36M | -1.90M | -2.43M | -2.39M | -2.34M |
| Income Before Tax | -1.48M | -2.48M | -2.33M | -2.30M | -2.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.48M | -2.48M | -2.33M | -2.30M | -2.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.48M | -2.48M | -2.33M | -2.30M | -2.30M |
| EBIT | -1.36M | -1.90M | -2.43M | -2.39M | -2.34M |
| EBITDA | -1.34M | -1.88M | -2.41M | -2.36M | -2.09M |
| EPS Basic | -7.75 | -- | -- | -- | -- |
| Normalized Basic EPS | -4.85 | -- | -- | -- | -- |
| EPS Diluted | -7.75 | -- | -- | -- | -- |
| Normalized Diluted EPS | -4.85 | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 191.10K | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 191.10K | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
